Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:alpha-galactosylceramide
go back to main search page
Accession:CHEBI:132148 term browser browse the term
Definition:A galactosylceramide in which the galactosyl residue has alpha anomeric conofiguration.
Synonyms:related_synonym: Formula=C10H17NO8R2;   SMILES=[C@H]([C@@H](*)O)(NC(=O)*)CO[C@H]1O[C@@H]([C@@H]([C@@H]([C@H]1O)O)O)CO;   alpha-D-galactosyl-N-acylsphingosine;   alpha-D-galactosyl-N-acylsphingosines;   alpha-galactocerebroside;   alpha-galactocerebrosides;   alpha-galactosylceramides
 xref_mesh: MESH:C493154
 xref: PMID:27242221 "Europe PMC"


show annotations for term's descendants       view all columns           Sort by:
 
alpha-galactosylceramide term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Gpt glutamic--pyruvic transaminase JBrowse link 7 117,759,083 117,761,932 RGD:6480464
G Ifng interferon gamma JBrowse link 7 61,337,383 61,341,419 RGD:6480464
G Il4 interleukin 4 JBrowse link 10 38,963,979 38,969,531 RGD:6480464

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19749
    chemical entity 19747
      atom 19745
        nonmetal atom 19618
          carbon atom 19517
            organic molecular entity 19517
              lipid 16966
                sphingolipid 172
                  ceramide 95
                    cerebroside 3
                      galactosylceramide 3
                        alpha-galactosylceramide 3
                          N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-11-phenylundecan-2-yl]hexacosanamide 0
                          N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-13-phenyltridecan-2-yl]hexacosanamide 0
                          N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-6-phenylhexan-2-yl]hexacosanamide 0
                          N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-8-phenyloctan-2-yl]hexacosanamide 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19749
    subatomic particle 19745
      composite particle 19745
        hadron 19745
          baryon 19745
            nucleon 19745
              atomic nucleus 19745
                atom 19745
                  main group element atom 19630
                    p-block element atom 19630
                      carbon group element atom 19523
                        carbon atom 19517
                          organic molecular entity 19517
                            organic group 18427
                              organic divalent group 18418
                                organodiyl group 18418
                                  carbonyl group 18305
                                    carbonyl compound 18305
                                      carboxylic acid 17972
                                        carboacyl group 17080
                                          univalent carboacyl group 17080
                                            carbamoyl group 16809
                                              carboxamide 16809
                                                ceramide 95
                                                  cerebroside 3
                                                    galactosylceramide 3
                                                      alpha-galactosylceramide 3
                                                        N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-11-phenylundecan-2-yl]hexacosanamide 0
                                                        N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-13-phenyltridecan-2-yl]hexacosanamide 0
                                                        N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-6-phenylhexan-2-yl]hexacosanamide 0
                                                        N-[(2S,3S,4R)-1-(alpha-D-galactosyloxy)-3,4-dihydroxy-8-phenyloctan-2-yl]hexacosanamide 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.